Fundraising Fox

Telegraph Hill Partners2017 Investments

3 investments dated 2017 · listed companies and verified rows first · show all

Akoya BiosciencesJul 2017SEC filingmedium confidence

San Francisco, US

Garry Nolan(Director)Thomas Raffin(Director)Matthew Winkler(Director)Brian McKelligon(Executive Officer)

BoardRob Hart(Executive Officer)

Board seatRobert Shepler· per SEC Form D · $9M raise · filed Jul 2017

Aquaro HistologyMay 2017SEC filinghigh confidence

BiotechAnn Arbor, US

Thomas Raffin(Director)Alberto Elli(Executive Officer, Director)Jack Ball(Executive Officer, Director)

Board seatDeval LashkariRob Hart· per SEC Form D · $9.8M raise · filed Jun 2017

Rarecyterarecyte.comJul 2017SEC filingmedium confidence

Seattle, US

Ronald Seubert(Executive Officer, Director, Promoter)Evan Castiglia(Executive Officer)Joseph Victor(Executive Officer, Director)Frank Witney(Director)Eric Kaldjian(Executive Officer)

Board seatRobert Shepler· per SEC Form D · $16.3M raise · filed Aug 2017

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.